|
Clariant
net stays flat at Rs 5.72 crore
Mumbai: Clariant (India) has posted a 1.24 per
cent increase in net profit to Rs 5.72 crore for the quarter
ended September 2002 as compared to Rs 5.65 crore in the
corresponding quarter last year.
Back
to News Review index page
Rediff.com
records lower operating profit at $2 million
Mumbai: Nasdaq-listed Rediff.com India Limited
has reported an operating profit of $2 million for the
quarter ended September 2002.
Back
to News Review index page
Xbox
to debut in 3 more Asian markets
Bangalore: Software giant Microsoft, which this
year slashed prices for its Xbox game console, said on
Thursday that it will begin selling the green-and-black
device in three Asian markets in late November.
Back
to News Review index page
Indian
Rayon Q2 net rises 60% to Rs 38 cr, sales up 12%
Mumbai: Indian Rayon, the Aditya Birla group company,
has recorded a 60% increase in net profit to Rs 37.7 crore
during the second quarter ended September 30, '02 as compared
with Rs 15.1 crore in the same period last year.
Back
to News Review index page
Torrent
Q2 net rises 26%
Mumbai: Torrent Pharmaceuticals has registered
net profit of Rs 16.3 crore for the second quarter ended
September 30, '02, an increase of 26% compared to Rs 12.9
crore in the corresponding quarter last year.
Back
to News Review index page
Nicholas
Piramal Q2 net up 85.72%
Mumbai: Nicholas Piramal India has posted a 85.72
per cent rise in net profit at Rs 26.15 crore for the
second quarter ended September 30, 2002, compared to Rs
14.08 crore in same period of previous fiscal.
Back
to News Review index page
Ranbaxy
woos Aventis Pasteur for R&D tie-up
New Delhi: After signing up an exclusive marketing
deal for the Verorab vaccine, Ranbaxy is wooing Aventis
Pasteur for a strategic tie-up in the field of R&D
for joint development of vaccines for infectious diseases
common in India.
Back
to News Review index page
Zydus
to launch four vaccines
Mumbai: Pharma major Zydus Cadila is actively eyeing
the nearly Rs 350-crore vaccine market in India by lauching
four more vaccines.
Back
to News Review index page
Cipla
to supply CFC-free inhalers to German firms
Mumbai: Cipla, India's second-largest pharma company
by market share, has tied up with three drugmakers in
Germany for supplying chlorofluorocarbons (CFC)-free inhalers
containing budesonide, an asthma medication.
Back
to News Review index page
DRL
net takes 31% hit on expiry of Fluoxetine
Hyderabad: Dr Reddy's whose sales were heavily
skewed towards the US generics markets on account of its
one-time marketing rights exclusivity on Fluoxetine drug,
has suffered a setback after the expiry of the product’s
exclusivity.
Back
to News Review index page
KAPL
to focus on lifestyle drugs
Bangalore: Karnataka Antibiotics & Pharmaceuticals
Ltd is planning Rs 20-crore investment to modernise its
manufacturing facilities.
Back
to News Review index page
Daimler
rolls out Merc E-class
Pune: Daimlerchrysler India on Thursday launched
the new Mercedes E - class at its facility in Pune. The
new car, the E-240 petrol which makes its debut on Indian
roads 10 months after its world premiere at the International
Brussels Motor show in January 2002, will come with a
price tag of Rs 33.9 lakh in Mumbai, exclusive of octroi,
registration and other levies.
Back
to News Review index page
Pepsi
runs short of Slice cocktail pulp
New Delhi: Pepsi Foods, which rolled out a series
of fruit cocktail variants under its Slice brand some
months ago in cartons, is faced with an unusual predicament.
Just when the product offtake is on the upswing, the soft
drinks major has run out of fruit pulp for some of its
cocktail variants.
Back
to News Review index page
Nalco
to file draft prospectus with SEC by Nov 15
New Delhi: November 15 date has been set for filing
a draft prospectus with the Securities and Exchange Commission
(SEC) of the US for the planned 20 per cent American depository
receipts (ADR) float of the company's shares.
Back
to News Review index page
SC
to pronounce Kudremukh PIL ruling today
New delhi: The Supreme Court on Thursday said that
it will pronounce its verdict on the public interest litigation
against Kudremukh Iron Ore Company Ltd on Friday.
Back
to News Review index page
Maars
reworking business strategy
Chennai: Maars Software International Ltd has started
a consolidation exercise. It is reworking its business
strategy and seeking additional funds to clear some of
the liabilities.
Back
to News Review index page
Pajero
rolls out of HM's new Chennai plant
Chennai: Hindustan Motor (HM) on Thursday rolled
out its first Pajero from the new facilities here that
cost the company Rs 12 crore to set up.
Back
to News Review index page
Cosmo
Films plans new production line
New Delhi: Cosmo Films Ltd has firmed up plans
to install a new production line in its Aurangabad facility
with fresh investments of Rs 50 crore which will be funded
partially through internal accruals and partially through
debts.
Back
to News Review index page
Zydus
Cadila in talks for manufacturing typhoid vaccines
Mumbai: Zydus Cadila Health Care Ltd is in negotiations
with a foreign player for buying technology for manufacturing
typhoid vaccines.
Back
to News Review index page
Diversified
profile plans ticking right for ITC
Kolkata: For the second consecutive quarter, agri-business
and paperboards divisions boosted reported profits at
ITC. Its cigarette business also grew during the quarter,
resulting in a 13 per cent rise in earnings per share.
Back
to News Review index page
Maruti
tops in customer satisfaction
New Delhi: Maruti Udyog ranks highest in customer
satisfaction with automotive dealer service for the third
consecutive year, as per the J.D. Power Asia Pacific 2002
India Customer Satisfaction Index (CSI) Study released.
Back
to News Review index page
|
